PubMed:32338224 / 9766-9939 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T290 7-20 CHEBI:52217 denotes pharmacologic
T291 7-20 CHEBI:52217 denotes pharmacologic
T292 76-80 G_3 denotes ACE2
T293 76-80 PG_10 denotes ACE2
T294 76-80 PR:000003622 denotes ACE2
T295 106-117 UBERON:0001004 denotes respiratory
T296 131-142 UBERON:0002349 denotes myocarditis
T297 146-154 SP_7 denotes COVID-19

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T24 36-39 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T57 131-142 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T58 146-154 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T131 5-6 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T62 36-39 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T13 131-142 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T60 0-173 DRI_Challenge denotes From a pharmacologic point of view, RAS inhibition leads to upregulation of ACE2, thus, attenuating acute respiratory syndrome and myocarditis in COVID-19-infected patients.

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T60 0-173 Sentence denotes From a pharmacologic point of view, RAS inhibition leads to upregulation of ACE2, thus, attenuating acute respiratory syndrome and myocarditis in COVID-19-infected patients.